Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-14 09:41 am Sale |
2024-09-30 | 13G | Relmada Therapeutics, Inc. RLMD |
Deep Track Capital, LP | 674,833 2.240% |
-1,369,674 (-66.99%) |
Filing History |
| 2024-03-06 4:15 pm Sale |
2022-12-31 | 13G | Relmada Therapeutics, Inc. RLMD |
PERCEPTIVE ADVISORS LLC | 0 0.000% |
-2,099,952 (Position Closed) |
Filing History |
| 2024-02-14 08:53 am Sale |
2023-12-31 | 13G | Relmada Therapeutics, Inc. RLMD |
Deep Track Capital, LP | 2,044,507 6.790% |
-793,311 (-27.95%) |
Filing History |
| 2024-02-14 07:49 am Sale |
2023-12-31 | 13G | Relmada Therapeutics, Inc. RLMD |
RTW Investments, LP | 0 0.000% |
-2,067,824 (Position Closed) |
Filing History |
| 2024-02-13 5:13 pm Sale |
2023-12-29 | 13G | Relmada Therapeutics, Inc. RLMD |
The Vanguard Group | 1,310,805 4.350% |
-206,175 (-13.59%) |
Filing History |
| 2023-07-07 4:35 pm Sale |
2023-06-30 | 13G | Relmada Therapeutics, Inc. RLMD |
BLACKROCK INC BLK |
605,254 2.000% |
-1,257,888 (-67.51%) |
Filing History |
| 2023-02-14 4:45 pm Sale |
2022-12-31 | 13G | Relmada Therapeutics, Inc. RLMD |
RA Capital Management, L.P. | 0 0.000% |
-2,000,000 (Position Closed) |
Filing History |
| 2023-02-14 4:13 pm Sale |
2022-12-31 | 13G | Relmada Therapeutics, Inc. RLMD |
Point72 Asset Management, L.P. | 56,207 0.200% |
-2,045,830 (-97.33%) |
Filing History |
| 2023-02-14 11:56 am Sale |
2022-12-31 | 13G | Relmada Therapeutics, Inc. RLMD |
BIOTECHNOLOGY VALUE FUND L P | 0 0.000% |
-1,647,400 (Position Closed) |
Filing History |
| 2023-02-14 10:10 am Sale |
2022-12-31 | 13G | Relmada Therapeutics, Inc. RLMD |
RTW Investments, LP | 2,067,824 6.900% |
-118,500 (-5.42%) |
Filing History |
| 2023-02-14 08:56 am Purchase |
2022-12-31 | 13G | Relmada Therapeutics, Inc. RLMD |
Deep Track Capital, LP | 2,837,818 9.430% |
356,818 (+14.38%) |
Filing History |
| 2023-02-14 08:14 am Sale |
2022-12-31 | 13G | Relmada Therapeutics, Inc. RLMD |
Citadel Advisors LLC | 511,316 1.700% |
-823,557 (-61.70%) |
Filing History |
| 2023-02-09 11:30 am Purchase |
2022-12-30 | 13G | Relmada Therapeutics, Inc. RLMD |
The Vanguard Group | 1,516,980 5.040% |
1,516,980 (New Position) |
Filing History |
| 2023-02-01 4:54 pm Purchase |
2022-12-31 | 13G | Relmada Therapeutics, Inc. RLMD |
BLACKROCK INC BLK |
1,863,142 6.200% |
477,907 (+34.50%) |
Filing History |
| 2022-12-20 3:50 pm Purchase |
2022-12-12 | 13G | Relmada Therapeutics, Inc. RLMD |
KOTLER KEVIN | 1,899,930 6.300% |
1,899,930 (New Position) |
Filing History |
| 2022-10-21 4:01 pm Purchase |
2022-10-13 | 13G | Relmada Therapeutics, Inc. RLMD |
Deep Track Capital, LP | 2,481,000 8.250% |
2,481,000 (New Position) |
Filing History |
| 2022-10-17 4:08 pm Purchase |
2022-10-07 | 13G | Relmada Therapeutics, Inc. RLMD |
Citadel Advisors LLC | 1,334,873 4.400% |
1,334,873 (New Position) |
Filing History |
| 2022-10-14 9:10 pm Purchase |
2022-10-13 | 13G | Relmada Therapeutics, Inc. RLMD |
Point72 Asset Management, L.P. | 2,102,037 7.300% |
2,102,037 (New Position) |
Filing History |
| 2022-09-23 4:31 pm Purchase |
2022-09-16 | 13G | Relmada Therapeutics, Inc. RLMD |
PERCEPTIVE ADVISORS LLC | 2,099,952 7.000% |
2,099,952 (New Position) |
Filing History |
| 2022-02-14 4:19 pm Purchase |
2021-03-26 | 13G | Relmada Therapeutics, Inc. RLMD |
Venrock Healthcare Capital Partners II, L.P. | 2,270,072 8.200% |
1,601,632 (+239.61%) |
Filing History |